Tempus AI Inc Class A common stock TEM
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Tempus Presents Data Demonstrating AI-Enabled Pre-Screening Can Help Identify Patients for Biomarker Testing in NSCLC
-
Tempus to Report Third Quarter 2026 Financial Results on November 2
-
Ambry Genetics Announces GenomeNext™, a Whole Genome Sequencing Test Solution to Improve Diagnosis for Rare Diseases
-
Tempus Enters Multiyear Collaboration With Moderna, Merck Aimed at Commercializing Cancer Drug
-
Tempus Announces Multi-Year Collaboration with Moderna and Merck
-
AI Drug Discovery Forecasts Vary Widely as Sector Shifts to Deployment
-
Tempus Announces 13 Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2026
-
Tempus Receives FDA Clearance for its ECG-MR AI Product Designed to Identify Undiagnosed Mitral Regurgitation
Trading Information
- Previous Close Price
- $66.75
- Day Range
- $66.00–68.93
- 52-Week Range
- $40.77–93.46
- Bid/Ask
- $66.85 / $67.40
- Shares Outstanding
- 181.56M
- Market Cap
- $12.30B
- Volume/Avg
- 3M / 7M
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 8.42
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
- Sector
- Healthcare
- Industry
- Health Information Services
- Stock Style Box
- Small Growth
- Total Number of Employees
- 3,800
- Website
- https://www.tempus.com
Valuation
|
Metric
|
TEM
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 27.45 |
Price/Sales | 8.42 |
Price/Cash Flow | 796.12 |
Price/Earnings
TEM
Financial Strength
|
Metric
|
TEM
|
|---|---|
Quick Ratio | 3.05 |
Current Ratio | 3.30 |
Interest Coverage | −3.88 |
Quick Ratio
TEM
Profitability
|
Metric
|
TEM
|
|---|---|
Return on Assets (Normalized) | −5.83% |
Return on Equity (Normalized) | −28.69% |
Return on Invested Capital (Normalized) | −5.18% |
Return on Assets
TEM
Health Information Services Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Veeva Systems Inc Class A
VEEV
| LOCK|P<!@>cB | LOCK|^P | $52B | |||
| Pro Medicus Ltd ADR
PMDIY
| — | LOCK|?@&B | $14B | |||
| Pro Medicus Ltd
PMCUF
| — | LOCK|$@Wz< | $14B | |||
| BrightSpring Health Services Inc
BTSG
| — | LOCK|drN#T | $12B | |||
| Hinge Health Inc Ordinary Shares - Class A
HNGE
| — | LOCK|?^hy | $9B | |||
| HealthEquity Inc
HQY
| — | LOCK|jK>#Q | $8B | |||
| M3 Inc
MTHRF
| — | LOCK|QbnN$ | $8B | |||
| M3 Inc ADR
MTHRY
| — | LOCK|z!r& | $8B | |||
| Doximity Inc Class A
DOCS
| — | LOCK|>r | $6B |
United States